| Popis: |
Aisanov Z, Avdeev S, Arkhipov V, Belevskiy A, Chuchalin A,Leshchenko I, Ovcharenko S, Shmelev E, Miravitlles M.Int J Chron Obstruct Pulmon Dis. 2018;13:183–187.Page 186, Disclosure, the text “The authors report no conflictsof interest in this work” should read “SA has receivedspeaker/consultancy fees from Boehringer Ingelheim,AstraZeneca, Chiesi, Teva and Novartis; non-financialsupport from Boehringer Ingelheim, Chiesi and Novartis;and research grants from AstraZeneca, GlaxoSmithKline andNovartis. MM has received speaker fees from BoehringerIngelheim, Chiesi, Cipla, Menarini, Rovi, Bial, CSL Behring,Grifols and Novartis; consultancy fees from BoehringerIngelheim, Chiesi, GlaxoSmithKline, Bial, Gebro Pharma,CSL Behring, Laboratories Esteve, Mereo BioPharm, VeronaPharma, pH Pharma, Novartis and Grifols; and research grantsfrom GlaxoSmithKline and Grifols. ZA has received speaker/consultancy fees from Boehringer Ingelheim, AstraZeneca,Chiesi, Teva and Novartis, GlaxoSmithKline; non-financialsupport from Boehringer Ingelheim, GSK and Novartis; andresearch grants from AstraZeneca, GlaxoSmithKline andNovartis. The authors report no other conflicts of interestin this work”.Read the original article |
